Oral Administration of DCI to Women With PCOS
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Polycystic Ovary Syndrome
In brief
To determine if oral DCI administration to women with PCOS increases the total DCI content in urine and blood, and, if so, if that change is accompanied by i) an increase in DCI-IPG release in blood (as determined by bioactivity) during an oral glucose challenge and ii) an increase in whole-body insulin sensitivity.
Key facts
- Study ID
- NCT00497653
- Run by
- Virginia Commonwealth University
- People needed
- 13
- Starts
- 2001-02-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2011-11-16
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
Where it is running
- General Clinical Research Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.